FOLD — Amicus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapNeutral

Annual balance sheet for Amicus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	453	483	482	294	286
Net Total Accounts Receivable
Net Total Receivables	33.3	46.9	52.7	66.2	87.6
Total Inventory
Prepaid Expenses
Total Current Assets	520	579	597	424	483
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	81	67.2	63.1	60.3	58
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	850	887	905	724	778
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	129	130	146	139	168
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	374	600	598	601	618
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	476	286	307	123	160
Total Liabilities & Shareholders' Equity	850	887	905	724	778
Total Common Shares Outstanding